Racing a clock somebody else set: management describes an outside deadline already driving the company's current work
The model's full reasoning — Q4 2017 call → NOThe question asks whether management describes the company as currently working against a dated deadline set by someone outside the company, with the company visibly organizing operations around hitting that date, and the payoff sitting on the other side of the date. Let me examine the transcript for any such situation. Key candidates: 1. The FDA nerve block sNDA - the AdCom was in February, PDUFA date of April 6 was mentioned. But the AdCom already happened, and the company is in discussions with FDA about next steps. The PDUFA date of April 6 was mentioned by Gary Nachman in a question, and Dave responded about not changing field force mix. But the AdCom vote was disappointing, and the company is now in dialogue with FDA. This doesn't seem like a current deadline the company is working to. 2. CMS reimbursement - Dave mentioned "We applied in December and if we are granted a code it would take effect January 1, 2019. Around the middle of this year, CMS will publish a draft of their proposed rule to take effect the following year." This is a CMS cycle, but the company is working with CMS to have EXPAREL unbundled. The middle of this year CMS publishes a draft rule. Is the company working to that date? It's more of a policy advocacy effort, not a production/launch deadline. 3. The UK manufacturing - "first commercial manufacturing on track to begin in the second half of 2018" - this is the company's own timeline, not externally set. 4. The C-section study - "we expect data later this year" - internal timeline. 5. The pediatric plan - "we expect to meet with them around the middle of this year" - this is a meeting, not a deadline. 6. The J&J partnership - PEAK programs, AAOS meeting next month - AAOS is an external event, but it's a medical society meeting, a routine industry event. The company is preparing for it, but is this a "deadline" that the company must hit with meaningful payoff? It's a conference, not a launch or production deadline. Let me think about the CMS J-code more carefully. The company applied in December for a code that would take effect January 1, 2019. CMS will publish a draft rule around the middle of this year. The company is working with CMS to have EXPAREL unbundled within that draft rule. This is an external process with fixed dates (CMS's rulemaking calendar). The payoff - separate reimbursement - would be significant.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| RCEL | AVITA Medical, Inc. | Q1 2024 | 2024-05-14 | F |
| RLX | RLX Technology Inc. | Q1 2022 | 2022-05-20 | C |
| AKBA | Akebia Therapeutics, Inc. | Q3 2021 | 2021-11-09 | C+ |
| EGY | VAALCO Energy, Inc. | Q2 2021 | 2021-08-12 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| AEHR | Aehr Test Systems | Q2 2017 | 2017-01-05 | F |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
RLX · Q1 2022 → YESThe question is about whether management describes the company as currently working against a dated deadline set by someone outside the company, organizing operations around hitting that date, with th...
AKBA · Q3 2021 → YESThe question is: Does management describe the company as CURRENTLY WORKING AGAINST A DATED DEADLINE THAT SOMEBODY OUTSIDE THE COMPANY HAS SET... and organizing operations around hitting that date, wit...
EGY · Q2 2021 → YESThe question is about whether management describes the company as currently working against a dated deadline set by someone outside the company, organizing operations around hitting that date, with th...